Latest News Highlights

Public Alert - Counterfeit Cancer Medicine (Sutent)

Wednesday, 9th August 2017

 Public Alert - Counterfeit Cancer Medicine (Sutent)

National Drug Authority (NDA) informs health service providers and the public that it has impounded some unregistered and counterfeit medicines; Sutent (sunitinib malate) tablets packed in plastic jar on the market that bears the following features:

Sutent 12.5mg , Batch no : NC 1060 Expiry date : 02/2019

Sutent distinguishing features of the genuine from the counterfeit



Is manufactured by Pfizer


Claimed to be "Made in Sweden AstraZeneca 2014. Astrazeneca and Turbuhaler are trade marks of Astrazeneca group of companies. AstraZeneca Pty Ltd Alma Road, North Ryde NSW 2113 Australia"

Wrong spelling of the name AstraZeneca in some places as "AstraZenaca" and group as "grroup"




Is supplied only as hard gelatin capsules


 Is presented as bluish - grey tablets